Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral minoxidil 2.5 mg versus 5 mg for male pattern hair loss
RBR-6mjd8bxPhase 3Recruiting
- Sponsor
- UNESP Botucatu Medical School
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of minoxidil in androgenetic alopecia (AGA) (2 arms), sponsored by UNESP Botucatu Medical School. Started Aug 2022; status: recruiting.
02
Drugs
minoxidil
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on RBR-6mjd8bx.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6mjd8bx.